Lantern Pharma Inc (NAS:LTRN)
$ 3.74 -0.15 (-3.86%) Market Cap: 40.34 Mil Enterprise Value: 14.19 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 39/100

Lantern Pharma Inc. Annual Shareholders Meeting Transcript

May 19, 2021 / 03:00PM GMT
Release Date Price: $13.95 (-4.09%)
Panna Sharma
Lantern Pharma Inc. - President, CEO & Director

Good morning, and welcome to Lantern Pharma's 2021 Annual Meeting of Stockholders. My name is Panna Sharma, and I'm President and CEO of Lantern Pharma. I will be presiding at the meeting today. Thank you all for attending.

Also in attendance at the meeting today are members of our Board of Directors; also Dean Katsoupas and Michele Epstein of EisnerAmper, our public accounting firm and auditor. David Margrave, CFO and Secretary of Lantern Pharma, will also be acting as the secretary and inspector of elections for this meeting.

Now let me give you an outline of the plan for this meeting. As described in the notice and proxy statement that has been distributed and also available in the tab, you are entitled to participate and vote at this meeting if you are a stockholder as of the close of business on March 26, 2021, that is the record date for this meeting; or if you hold a legal proxy for the meeting provided by your bank, broker or nominee. If you have a voting control number issued through Broadridge and wish to vote

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot